Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Important Limitations and Warnings Honesty about AOD-9604's limitations serves users better than hype
Athletes managing recurring soft tissue issues: Patients with high training volume who are managing recurring tendon irritation, muscle strain patterns, or joint inflammation that limits performance and recovery
Common gastrointestinal adverse effects reported in clinical trials include: Nausea (approximately 44% of patients) Diarrhoea (approximately 30%) Vomiting (approximately 24%) Constipation (approximately 24%) Abdominal pain (approximately 20%) Dyspepsia (approximately 9%) These effects are typically most pronounced during dose escalation and tend to diminish over time as the body adapts
Health 31 , 196214 (2008)
Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat
